Arimoclomol citrate Chemical Properties,Usage,Production
Uses
Arimoclomol is a co-inducer of HSP that acts through heat shock factor 1 (HSF1) in cells undergoing cellular stress. Has therapeutic potential in motor neuron degenerative diseases. Potential treatment for liposomal storage disorders, such as Niemann-Pick disease type C.
in vivo
Arimoclomol (BRX-220; 20 mg/kg; orally administered for 5 d) has a protective effect against cholecystokinin-octapeptide (CCK)-induced acute pancreatitis[1].
Animal Model:
Male Wistar rats weighing 240 to 270 g[1]
Dosage:
20 mg/kg
Administration:
Administered intragastrically, for 5 days
Result:
Had a protective effect against CCK-induced acute pancreatitis.